New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Chemir Pharma Services Changes Name to Azopharma

Chemir Pharma Services has changed its name to Azopharma in response to extensive growth and commitment as a contract pharmaceutical services provider.

Azopharma continues to support Specific Stand-Alone cGMP Services and complete Phase I Development Programs, including the manufacturing of clinical trial material.

Azopharma’s Phase I Express enables pharmaceutical companies to move quickly and efficiently toward clinical trials. Phase I Express includes preformulation, formulation, analytical R&D, QC release, stability, manufacturing, packaging and labeling of clinical supplies for Phase I development.

“Timing is a critical factor on the road to successful clinical study,” explains Phil Meeks, CEO of Azopharma. “We can now assist our customers in all phases of drug development for Phase I clinical supplies. Our Phase I Express will raise the bar in the industry and bring unsurpassed speed to the development of clinical materials.”

“In product development, it all comes down to the scientists, their commitment and the application of experience. Partnering with the right people with the right experience can give you the confidence of assured success. Over the past two years, we have experienced significant growth…thanks to our customers’ belief in us and our service and commitment to them. We have stayed true to our corporate values,” says Phil Meeks.

Azopharma helps bring new medicines to the marketplace. FDA registered and cGMP compliant, this full-service contract research and development organization supports the development and commercialization of pharmaceutical, biotech and medical device products. Capabilities include synthetic chemistry, characterization services, preformulation evaluations, formulations development, methods development/validation, quality control testing and stability studies.

At Azopharma, we are passionate for science, focused on customers and persistent in successful contract pharmaceutical product development.


Contact: Phil Meeks, CEO, Azopharma
10320 USA Today Way
Miramar, FL 33025
1 (954) 433-7480

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.